CDKN2A and head and neck squamous cell carcinoma: In conclusion, the 24-miRNA signature accurately predicts HPV-status and, within HPV-positive HNSCC, even better reflects prognosis and molecular biology compared to HPV-typing using p16/HPV DNA status alone.